Clinical Trial Update: Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance Areas [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting completion of a study evaluating telithromycin for adults with mild to moderate community-acquired pneumonia in areas with high b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Telithromycin (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Pneumonia | Phase 4 | Status: COMPLETED